EASE: The Materna Prep Pivotal Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

December 11, 2019

Primary Completion Date

July 30, 2026

Study Completion Date

August 30, 2026

Conditions
Vaginal DeliveryPelvic Organ Prolapse
Interventions
DEVICE

Materna Prep Device

Materna Prep Device

OTHER

Standard of Care (SOC)

Standard of Care (SOC)

Trial Locations (22)

10032

Columbia University Irving Medical Center, New York

11355

New York Presbyterian -Queens (NYPQ), Flushing

19140

Hospital of the University of Pennsylvania, Philadelphia

Lewis Katz School of Medicine at Temple, Philadelphia

19718

Christiana Care - Center for Women's & Children's Health, Newark

20010

MedStar Washington Hospital Center, Washington D.C.

33606

USF Ob/Gyn, Tampa

35233

University of Alabama at Birmingham, Birmingham

43210

The Ohio State University Wexner Medical Center, Columbus

44109

The Metro Health System, Cleveland

55905

Mayo Clinic, Rochester

77030

Baylor College of Medicine, Houston

77573

Maximos Ob/Gyn, League City

83404

The Healing Sanctuary, Idaho Falls

84108

Univ of Utah Ob/Gyn, Salt Lake City

90095

University of California Los Angeles, Los Angeles

94040

El Camino Hospital, Mountain View

94904

La Follette Ob/Gyn, Greenbrae

97239

Oregon Health and Science University, Portland

08103

The Cooper Health System, Camden

08901

Rutgers Robert Wood Johnson University Hospital, New Brunswick

07103

Rutgers New Jersey Medical School, Newark

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

University of Michigan

OTHER

lead

Materna Medical

INDUSTRY

NCT03973281 - EASE: The Materna Prep Pivotal Study | Biotech Hunter | Biotech Hunter